Neurotransmitters involved in the opioid regulation of prolactin secretion at the end of pregnancy in rats

Neuroendocrinology

Volumn 80, Issue 1, 2004, Pages 11-20

  Soaje, Marta ^a   Bregonzio, Claudia ^b   Carón, Rubén W ^a   Deis, Ricardo P ^a  

^a Laboratorio de Reproduccion y Lactancia Mendoza   (Argentina)

^b FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

Catecholamines; Gonadal steroids; Opioid antagonists; Opioid peptides; Pregnancy; Prolactin; Serotonin

Indexed keywords

3 AMINO 2 (3 CARBOXYPROPYL) 6 (4 METHOXYPHENYL)PYRIDAZINIUM BROMIDE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 3,4 DIHYDROXYPHENYLACETIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; BETA ENDORPHIN; DELTA OPIATE RECEPTOR AGONIST; DOPAMINE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR AGONIST; KETANSERIN; MU OPIATE RECEPTOR AGONIST; NALOXONE; OPIATE; OPIATE ANTAGONIST; PHACLOFEN; PROLACTIN; SEROTONIN ANTAGONIST; SODIUM CHLORIDE;

ALKALINITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; EVALUATION; FEMALE; GABAERGIC SYSTEM; GESTATIONAL AGE; NEUROTRANSMISSION; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; RAT; REACTION TIME; SEROTONINERGIC SYSTEM; STATISTICAL SIGNIFICANCE;

ANALGESICS, OPIOID; ANIMALS; BETA-ENDORPHIN; BRAIN; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; FEMALE; GABA ANTAGONISTS; INJECTIONS, INTRAVENTRICULAR; NARCOTICS; NEUROTRANSMITTER AGENTS; PREGNANCY; PREGNANCY, ANIMAL; PROLACTIN; RATS; RATS, WISTAR; RECEPTORS, OPIOID, MU; SEROTONIN ANTAGONISTS;

EID: 5644300390     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080520     Document Type: Article

References (78)

1. Ferland L, Kledzik GS, Cusan L, Labrie F: Evidence for a role of endorphins in stress- and suckling-induced prolactin release in the rat. Mol Cell Endocrinol 1978;12:267-272.
2. Rossier J, French E, Rivier C, Shibasaki T, Guillemin R , Bloom FE: Stress-induced release of prolactin: Blockade by dexametaxone and naloxone may indicate β-endorphin mediation. Proc Natl Acad Sci USA 1980;77:666-669.
3. Ieiri T, Chen HT, Campbell GA, Meites J: Effects of naloxone and morphine on the proestrous surge of prolactin and gonadotropins in the rat. Endocrinology 1980;106:1568-1570.
4. Carón RW, Deis RP: Participation of opioid and serotoninergic systems in prolactin secretion induced by hypothalamic action of estradiol. Neuroendocrinology 1996;64:124-130.
5. Soaje M, Deis RP: A modulatory role of endogenous opioids on prolactin secretion at the end of pregnancy in the rat. J Endocrinol 1994;140:97-102.
6. Soaje M, Deis RP: Opioidergic regulation of prolactin secretion during pregnancy: Role of ovarian hormones. J Endocrinol 1997;155:99-106.
7. Soaje M, Deis RP: Participation of the opioid system in the regulation of prolactin secretion in androgenized rats: Effect of ovarian steroids. Eur J Pharmacol 1999;371:43-49.
8. Freeman ME, Kanyicska B, Lerant A, Nagy G: Prolactin: Structure, function and regulation of secretion. Physiol Rev 2000;80:1523-1631.
9. Evans CJ, Keith DE, Morrison H, Magendzo K, Edwards RH: Cloning of a delta opioid receptor by functional expression. Science 1992;258:1952-1955.
10. Chen Y, Mestek A, Liu J, Hurley JA, Yu L: Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol Pharmacol 1993;44:8-12.
11. Meng F, Xie GX, Thompson RC, Mansour A, Goldstein A, Watson SJ, Akil H: Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc Natl Acad Sci USA 1993;90:9954-9958.
12. Krulich L, Koenig JI, Conway S, McCann SM, Mayfield MA: Opioid κ receptor and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonist bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine. Neuroendocrinology 1986;42:75-81.
13. Leadem CA, Yagenova SV: Effects of specific activation of mu, delta and kappa opioid receptors on the secretion of luteinizing hormone and prolactin in the ovariectomized rat. Neuroendocrinology 1987;45:109-117.
14. Kapoor R, Willoughby JO: Activation of opioid receptors in the mediobasal hypothalamus stimulates prolactin secretion in the conscious rats. J Neuroendocrinol 1990;2:347-350.
15. Wilkinson M, Brawer JR, Wilkinson DA: Gonadal steroid-induced modification of opiate binding sites in anterior hypothalamus of female rats. Biol Reprod 1985:32:501-506.
16. Bridges RS, Ronsheim PM: Immunoreactive beta-endorphin concentrations in brain and plasma during pregnancy in rat: Possible modulation by progesterone and estradiol. Neuroendocrinology 1987;45:381-388.
17. Weiland NG, Wise PM: Estrogen and progesterone regulate opiate receptor densities in multiple brain regions. Endocrinology 1990;126:804-808.
18. Limonta P, Maggi R, Dondi D, Martini L, Piva F: Gonadal steroid modulation of brain opioid systems. J Steroid Biochem 1987;27:691-697.
19. Singh M, Millard WJ, Layden MP, Romano TM, Simpkins JW: Opiate stimulation of prolactin secretion is reversed by ovarian hormone treatment. Neuroendocrinology 1992;56:195-203.
20. Maggi R, Dondi D, Rovati GE, Martini L, Piva F, Limonta P: Binding characteristics of hypothalamic mu opioid receptors throughout the estrous cycle in the rat. Neuroendocrinology 1993;58:366-372.
21. Petraglia F, Baraldi M, Giarre G, Facchinetti F, Santi M, Volpe A, Genazzani AR: Opioid peptides of the pituitary and hypothalamus: Changes in pregnant and lactating rats. J Endocrinol 1985;105:239-245.
22. Hammer RP, Bridges RS: Preoptic area opioids and opiate receptors increase during pregnancy and decrease during lactation. Brain Res 1987;420:48-56.
23. Dondi D, Maggi R, Panerai AE, Piva F, Limonta P: Hypothalamic opiatergic tone during pregnancy, parturition and lactation in the rat. Neuroendocrinology 1991;53:460-466.
24. Ben-Jonathan N, Hnasko R: Dopamine as a prolactin (PRL) inhibitor. Endocr Rev 2001;22:724-763.
25. Apud JA, Cocchi D, Locatelli V, Masotto C, Muller EE, Racagni G: Biochemical and functional aspects on the control of prolactin release by the hypothalamo-pituitary GABAergic system. Psychoneuroendocrinology 1989;14:3-17.
26. Schally AV, Redding TW, Arimura A, Dupont A, Linthicum GL: Isolation of gamma-aminobutyric acid from pig hypothalami and demonstration of its prolactin release-inhibiting (PIF) activity in vivo and in vitro. Endocrinology 1977;100:681-691.
27. Locatelli V, Cocchi D, Frigerio C, Betti R, Krogsgaard-Larsen P, Racagni G, Muller EE: Dual γ-aminobutyric acid control of prolactin secretion in the rat. Endocrinology 1979;105:778-785.
28. Van de Kar LD, Rittenhouse PA, Li Q, Levy AD: Serotonergic regulation of renin and prolactin secretion. Behav Brain Res 1996;73:203-208.
29. Jahn GA, Deis RP: A possible dual regulation of prolactin release by the serotoninergic system in rats at pro-oestrus and during late pregnancy: Role of ovarian hormones. J Endocrinol 1987;112:367-374.
30. Jahn GA, Deis RP: Effect of serotonin antagonists on prolactin and progesterone secretion in rats: Evidence that the stimulatory and inhibitory actions of serotonin on prolactin release may be mediated through different receptors. J Endocrinol 1988;117:415-422.
31. Jahn GA, Deis RP: Dual modulation of prolactin release by the serotoninergic system in lactating rats. J Serotonin Res 1994;1:143-149.
32. Jahn GA, Kalia V, Wilson CA, Deis RP: Receptors and neurotransmitters involved in the dual modulation of prolactin release by the serotoninergic system in pregnant and lactating rats. J Reprod Fertil 1999;116:261-268.
33. Mallmann ES, Ribeiro MF, Spritzer PM: Effect of serotonin depletion by p-chlorophenylalanine on serum prolactin levels in estrogentreated ovariectomized rats: Insights concerning the serotoninergic, dopaminergic and opioid systems. Horm Metab Res 2001;33:337-342.
34. 2α in pregnant rats. Nature 1972;238:248-250.
35. Jahn GA, Alonso N, Deis RP: Ovarian and feto-placental factors and the regulation of prolactin release during pregnancy in the rat. J Reprod Fertil 1986;77:125-133.
36. Sagrillo CA, Voogt JL: Endogenous opioids mediate the nocturnal prolactin surge in the pregnant rat. Endocrinology 1991;129:925-930.
37. Paxinos G, Watson C: in: The Rat Brain in Stereotaxic Coordinates, ed 2. Sydney, Academic Press, 1986.
38. Leadem CA, Kalra SP: Effects of endogenous opioid peptides and opiates on LH and prolactin secretion in ovariectomized rats. Neuroendocrinology 1985;41:342-352.
39. Soaje M, Deis RP: Involvement of opioid receptor subtypes in both stimulatory and inhibitory effects of the opioid peptides on prolactin secretion during pregnancy. Cell Mol Neurobiol 2004;24:193-204.
40. Hartman RD, He JR, Barraclough CA: Gamma-aminobutyric acid A and B receptor antagonists increase luteinizing hormone-releasing hormone neuronal responsiveness to intracerebroventricular norepinephrine in ovariectomized estrogen-treated rats. Endocrinology 1990:127:1336-1345.
41. Niswender GD, Chen CL, Midgley AR Jr, Meites J, Ellis S: Radioimmunoassay for rat prolactin. Proc Soc Exp Biol Med 1969;130:793-797.
42. Robertson MC, Friesen HG: Two forms of rat placental lactogen revealed by radioimmunoassay. Endocrinology 1981;108:2388-2390.
43. Andrews ZB, Grattan DR: Opioid receptor subtypes involved in the regulation of prolactin secretion during pregnancy and lactation. J Neuroendocrinol 2003;15:227-236.
44. Mansour A, Fox CA, Akil H, Watson SJ: Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications. Trends Neurosci 1995;18:22-29.
45. North RA, Williams JT, Surprenant A, Christie MJ: Mu and delta receptors belong to a family of receptors that are coupled to potassium channels. Proc Natl Acad Sci USA 1987;84:5487-5491.
46. Loose MD, Kelly MJ: Opioids act at μ-receptors to hyperpolarize arcuate neurons via an inwardly rectifying potassium conductance. Brain Res 1990;513:15-23.
47. Wang L, Gintzler AR: Morphine tolerance and physical dependence: Reversal of opioid inhibition to enhancement of cyclic AMP formation. J Neurochem 1995;64:1102-1106.
48. Crain SM, Shen KF: Modulation of opioid analgesia, tolerance and dependence by Gscoupled, GM1 ganglioside-regulated opioid receptor functions. Trends Pharmacol Sci 1998;19:358-365.
49. Manzanares J, Lookingland KJ, Moore KE: Kappa opioid receptor-mediated regulation of dopaminergic neurons in the rat brain. J Pharmacol Exp Ther 1991;256:500-505.
50. Manzanares J, Wagner EJ, LaVigne SD, Lookingland KJ, Moore KE: Sexual differences in kappa opioid receptor-mediated regulation of tuberoinfundibular dopaminergic neurons. Neuroendocrinology 1992;55:301-307.
51. Callahan P, Baumann MH, Rabii J: Inhibition of tuberoinfundibular dopaminergic neural activity during suckling: Involvement of μ and κ opiate receptor subtypes. J Neuroendocrinol 1996;8:771-776.
52. Arbogast LA, Voogt JL: Endogenous opioid peptides contribute to suckling-induced prolactin release by suppressing tyrosine hydroxylase activity and messenger ribonucleic acid levels in tuberoinfundibular dopaminergic neurons. Endocrinology 1998;139:2857-2862.
53. Krulich L, Koenig JI, Conway S, McCann SM, Mayfield MA: Opioid κ receptor and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. II. GH and PRL release-inhibiting effects of the opioid kappa receptor agonists bremazocine and U-50,488. Neuroendocrinology 1986;42:82-87.
54. Kapoor R, Willoughby JO: Activation of opioid receptors in the mediobasal hypothalamus stimulates prolactin secretion in the conscious rats. J Neuroendocrinol 1990;2:347-350.
55. Selmanoff M: Rapid effects of hyperprolactinemia on basal prolactin secretion and dopamine turnover in the medial and lateral median eminence. Endocrinology 1985;116:1943-1952.
56. Demarest KT, Riegle GD, Moore KE: The rapid 'tonic' and the delayed 'induction' components of prolactin-induced activation of tuberoinfundibular dopaminergic neurons following the systemic administration of prolactin. Neuroendocrinology 1986;43:291-299.
57. DeMaria JE, Lerant AA, Freeman ME: Prolactin activates all three populations of hypothalamic neuroendocrine dopaminergic neurons in ovariectomized rats. Brain Res 1999;837:236-241.
58. Mangat HK, McCann SM: Acute inhibition of PRL and TSH secretion after intraventricular injection of PRL in ovariectomized rats. Am J Physiol 1983;244:E31-E36.
59. Milenkovic L, Parlow AF, McCann SM: Physiological significance of the negative short-loop feedback of prolactin. Neuroendocrinology 1990;52:389-392.
60. Foreman MM, Porter JC: Prolactin augmentation of dopamine and norepinephrine release from superfused medial basal hypothalamic fragments. Endocrinology 1981;108:800-804.
61. Horvath TL, Naftolin F, Leranth C: β-Endorphin innervation of dopamine neurons in the rat hypothalamus: A light and electron microscopic double immunostaining study. Endocrinology 1992;131:1547-1555.
62. Sagrillo CA, Voogt JL: Mechanisms for the stimulatory effects of opioidergic and serotoninergic input signals on prolactin in pregnant rats. Life Sci 1992;50:1479-1489.
63. Soaje M, DiNasso FE, Deis RP: Regulation by endogenous opioids of suckling-induced prolactin secretion in pregnant and lactating rats: Role of ovarian steroids. J Endocrinol 2002;172:255-261.
64. Ben-Jonathan N: Dopamine in hypophysial portal blood: Relationship to circulating prolactin in pregnant and lactating rats. Endocrinology 1980;106:690-696.
65. Hashimoto R, Kimura F: Effects of intraventricular injection of delta receptor antagonist ICI 154, 129 on the secretion of luteinizing hormone and prolactin in proestrous rat. Endocrinol Jpn 1991;38:213-218.
66. Kehoe L, Parman R, Janik J, Callahan P: Opiate receptor subtype involvement in the stimulation of prolactin release by β-endorphin in female rats. Neuroendocrinology 1993;57:875-883.
67. Jaworski-Parman R, Callahan P, Janik J: Immunoneutralization of β-endorphin blocks prolactin release during suckling without affecting tuberoinfundibular dopaminergic neural activity. Life Sci 1997;61:1301-1311.
68. Johnson MD, Crowley WR: Effects of opiate antagonists on serotonin turnover and on luteinizing hormone and prolactin secretion in estrogen- or morphine-treated rats. Neuroendocrinology 1984;38:322-327.
69. Koenig JI, Mayfield MA, Coppings RJ, McCann SM, Krulich L: Role of central nervous system neurotransmitters in mediating the effects of morphine on growth hormoneand prolactin-secretion in the rat. Brain Res 1980;197:453-468.
70. Flores CM, Hulihan-Giblin BA, Hornby PJ, Lumpkin MD, Kellar KJ: Partial characterization of neurotransmitter pathway regulating the in vivo release of prolactin. Neuroendocrinology 1992;55:519-528.
71. Kiss J, Leranth C, Halasz B: Serotoninergic endings on VIP-neurons in the suprachiasmatic nucleus and on ACTH-neurons in the arcuate nucleus of the rat hypothalamus: A combination of high resolution autoradiography and electron microscopic immunocytochemistry. Neurosci Lett 1984;44:119-124.
72. Horvath TL, Naftolin F, Leranth C: GABAergics and catecholaminergic innervation of mediobasal hypothalamic β-endorphin cells projecting to the medial preoptic area. Neuroscience 1992;51:391-399.
73. Blasquez C, Jegou S, Feuilloley M, Rosier A , Vandesande F, Vaudry H: Visualization of γaminobutyric acid A receptors on pro-opiomelanocortin- producing neurons in the rat hypothalamus. Endocrinology 1994;135:2759-2764.
74. Lee TY, Pan JT: Involvement of central GABAergic neurons in basal and diurnal changes of tuberoinfundibular dopaminergic neuronal activity and prolactin secretion. Life Sci 2001;68:1965-1975.
75. Wagner EJ, Goudreau JL, Moore KE Lookingland KJ: GABAergic regulation of tuberoinfundibular dopaminergic neurons in the male rat. Brain Res 1994;659:194-200.
76. Afione S, Debeljuk L, Seilicovich A, Pisera D, Lasaga M, Diaz MC, Duvilanski B: Substance P affects the GABAergic system in the hypothalamo-pituitary axis. Peptides 1990;11:1065-1068.
77. Afione S, Duvilanski B, Seilicovich A, Lasaga M, Diaz MC, Debeljuk L: Effects of serotonin on the hypothalamo-pituitary GABAergic system. Brain Res Bull 1990;25:245-249.
78. Kutlu S, Yilmaz B, Canpolat S, Sandal S, Ozcan M, Kumru S, Kelestimur H: Mu opioid modulation of oxytocin secretion in late pregnant and parturient rats. Involvement of noradrenergic neurotransmission. Neuroendocrinology 2004;79:197-203.